查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1995292

血液处理设备及耗材市场：按产品类型、技术、应用、最终用户和分销管道分類的全球市场预测，2026年至2032年

Blood Processing Devices & Consumables Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年血液处理设备和耗材市场价值为 552.5 亿美元，预计到 2026 年将成长至 587.9 亿美元，复合年增长率为 7.22%，到 2032 年将达到 900.5 亿美元。

主要市场统计数据
基准年 2025 552.5亿美元
预计年份：2026年 587.9亿美元
预测年份 2032 900.5亿美元
复合年增长率 (%) 7.22%

对影响血液处理设备和耗材未来部署的临床、技术、监管和营运趋势进行全面分析。

血液处理设备和耗材的市场格局正在不断演变，这受到临床需求、技术创新和日益严格的监管要求的共同影响。医疗机构、检查室管理人员和采购团队正面临着一个不断变化的环境，设备效能、耗材品质和工作流程整合决定临床可靠性和营运效率。本执行摘要概述了血液采集、分离、检测和储存流程决策者面临的最重要主题驱动因素和实际影响。

自动化、病原体控制创新和整合生命週期支援如何重新定义整体血液处理的采购重点和营运模式。

随着自动化技术的成熟、病原体减少技术的进步以及数据驱动的品质保证日益融入工作流程，血液处理生态系统正经历变革性的转变。自动化处理平台正从试点阶段走向高通量设施的主流部署，这改变了人工操作的作用，并重新定义了人员配置模式。随着这些平台的扩展，关注点正从单一功能的效能转向系统互通性和整个生命週期的总体拥有成本，催生了新的采购标准和对供应商服务的期望。

与关税相关的供应链重组和采购弹性策略正在重塑采购、生产在地化和检验供应商多元化。

美国近期推出的关税措施为製造商、经销商和终端用户带来了新的考量，不仅影响直接成本，也影响供应链结构、筹资策略和供应商选择。关税带来的价格压力促使企业重新评估零件采购，尽可能实现在地化生产，并寻求供应商多元化以降低风险。虽然这些策略转变短期内可能会增加复杂性，但从长远来看，它们也将加速对本地生产和经认证的替代供应链的投资。

将产品分类、自动化范式、临床应用、使用者画像和通路与策略挑战联繫起来的详细細項分析。

精细的細項分析揭示了产品类型、技术、应用、最终用户和分销管道中价值与风险的交集。在产品层面，耗材和医疗设备被区分开来。耗材包括抗凝血剂和添加剂、血袋和输血器、过滤器和检测套组，而医疗设备包括血浆分离机、离心机、病原体去除系统和储存设备。每类产品都有其自身的监管路径、耗材生命週期要求和使用者培训要求，这些都会影响部署速度和服务模式。

对美洲、欧洲、中东、非洲和亚太地区的监管复杂性、基础设施多样性和分销要求进行区域比较评估。

美洲、欧洲、中东、非洲和亚太地区的区域趋势差异显着，每个地区都有其独特的监管环境、报销体系和基础设施，这些因素都会影响产品的采用路径和供应商策略。在美洲，采购和临床网路通常强调规模和整合，因此更倾向于采用能够降低高容量医疗机构营运复杂性的整合解决方案和服务包。区域法规结构支援既定的检验流程，物流网路通常也便于医疗设备和耗材的集中配送。

在竞争格局和策略定位方面，我们强调有针对性的伙伴关係，以扩大我们的临床检验、综合服务网络和产品组合。

竞争格局主要由成熟的医疗设备製造商、专业耗材供应商以及提供创新自动化和诊断技术的新兴科技公司组成。主要企业透过结合检验的临床表现、完善的服务体係以及提供可互通的解决方案的能力来脱颖而出，这些解决方案能够适应不同的实验室资讯系统和医院工作流程。策略伙伴关係和有针对性的收购已成为企业常用的策略，旨在弥补病原体清除、自动化和低温运输解决方案方面的能力缺口，同时拓展其在医疗设备和耗材领域的业务组合。

领导企业在平衡创新、供应链韧性和以客户为中心的全生命週期支援方面面临的实际营运和商业挑战。

产业领导企业应优先考虑协作方式，在创新、供应链韧性和以使用者为中心的设计之间取得平衡。製造商需要投资可配置以适应各种处理能力的模组化自动化平台，同时确保与各种耗材相容，并减少客户过渡过程中的摩擦。同时，对完善的售后服务、远端诊断和软体更新进行投资，将确保运作并维护长期的客户关係。

透过结合关键相关人员的见解、监管映射和供应商概况，调查方法产生可操作和检验的市场资讯。

本研究整合了一手和二手资料，旨在建立基于证据的血液处理设备及耗材市场趋势洞察。一手资料包括对临床医生、检查室管理人员、采购负责人和技术负责人的结构化访谈，以及设备和耗材生命週期相关文件、临床检验报告和监管备案文件。二手资料包括同行评审的临床文献、技术标准和政策文件，以了解产品性能声明的背景及其影响因素。

透过整合强调检验的绩效、高度适应性的服务模式和强大的采购系统的策略挑战，我们确保长期的临床和商业性成功。

总之，成功的新兴参与企业和成熟企业都具备以下特点：经临床检验性能、灵活且以服务为导向的经营模式以及稳健的供应链。自动化和病原体去除技术的进步虽然带来了显着的临床和营运效益，但其应用需要可验证的互通性、简化的检验流程以及强大的售后支援。耗材的品质和相容性仍然是保障安全性和工作流程效率的关键，因此医疗设备製造商和耗材供应商之间的密切合作至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血液处理设备及耗材市场：依产品类型划分

  • 消耗品
    • 抗凝血剂和添加剂
    • 血袋和血包
    • 筛选
    • 检测套组
  • 装置
    • 血液分离装置
    • 离心机
    • 病原体去除系统
    • 储存装置

第九章 血液处理设备及耗材市场：依技术分类

  • 自动化处理
    • 全自动系统
    • 半自动系统
  • 手动处理

第十章 血液处理设备及耗材市场：依应用领域划分

  • 血液样本
  • 组分分离
  • 诊断测试
  • 病原体去除
  • 仓储/运输

第十一章 血液处理设备及耗材市场：依最终用户划分

  • 血库
  • 检查室
  • 医院和诊所
  • 研究机构

第十二章 血液处理设备及耗材市场：依通路划分

  • 直销
  • 销售代理
  • 电子商务

第十三章 血液处理设备及耗材市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 血液处理设备及耗材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 血液处理设备及耗材市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国血液处理设备与耗材市场

第十七章：中国血液处理设备及耗材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Baxter International
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Macopharma SA
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • ThermoGenesis Holdings, Inc.
Product Code: MRR-AB49FC1AB774

The Blood Processing Devices & Consumables Market was valued at USD 55.25 billion in 2025 and is projected to grow to USD 58.79 billion in 2026, with a CAGR of 7.22%, reaching USD 90.05 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.25 billion
Estimated Year [2026] USD 58.79 billion
Forecast Year [2032] USD 90.05 billion
CAGR (%) 7.22%

Comprehensive framing of clinical, technological, regulatory, and operational dynamics shaping the future adoption of blood processing devices and consumables

The landscape for blood processing devices and consumables is evolving at the intersection of clinical need, technological innovation, and tightening regulatory expectations. Providers, laboratory directors, and procurement teams are navigating a shifting environment in which device performance, consumable quality, and workflow integration determine clinical reliability and operational efficiency. This executive summary synthesizes the thematic drivers and practical implications that matter most to decision-makers managing blood collection, separation, testing, and storage pathways.

Across clinical settings, demand signals are increasingly shaped by the need to balance throughput with safety. Innovations in automated processing and pathogen reduction aim to reduce variability and enhance safety, while consumable design advances seek to streamline handling and extend shelf life. At the same time, regulatory scrutiny and compliance frameworks are prompting closer alignment between manufacturers and end users, focusing on traceability, validation protocols, and postmarket surveillance. The convergence of these forces is leading organizations to prioritize interoperability, supply chain resilience, and lifecycle support during procurement and technology adoption.

This introduction frames the subsequent analysis by highlighting how technical performance, user-centric design, and policy drivers are creating a more integrated, quality-focused market. It also establishes the lens through which we examine segmentation, regional dynamics, tariff effects, and competitive positioning to surface actionable perspectives for stakeholders across clinical, laboratory, and research environments.

How automation, pathogen mitigation innovations, and integrated lifecycle support are redefining procurement priorities and operational models across clinical blood processing

The blood processing ecosystem is undergoing transformative shifts as automation matures, pathogen mitigation technologies advance, and data-driven quality assurance becomes increasingly embedded in workflows. Automated processing platforms are moving from experimental adoption to mainstream deployment in high-volume centers, which is altering the role of manual methods and redefining staffing models. As these platforms scale, attention shifts from single-function performance to system interoperability and lifecycle total cost of ownership, prompting new procurement criteria and vendor-service expectations.

Simultaneously, pathogen reduction systems and enhanced diagnostics are raising the bar for safety while stimulating demand for compatible consumables and validated processing protocols. These technological strides are complemented by improvements in storage and transport equipment that enable extended preservation windows and better temperature control, thereby expanding logistical options for blood centers and hospitals. The cumulative effect is a market that favors modular, adaptable solutions capable of integrating into diverse clinical pathways.

Operationally, end users are placing a premium on traceability, real-time quality metrics, and simplified user interfaces to lower training burdens and reduce handling errors. Distribution models are also evolving: direct sales relationships persist for complex instruments while distributors and e-commerce channels grow in importance for standardized consumables and replacement parts. Together, these shifts create a more connected, efficiency-oriented environment that rewards manufacturers who combine robust engineering with responsive support and validated clinical workflows.

Tariff-driven supply chain realignment and procurement resilience strategies that reshape sourcing, production localization, and validated supplier diversification

Recent tariff actions in the United States have introduced new considerations for manufacturers, distributors, and end users that extend beyond immediate cost implications to influence supply chain architecture, sourcing strategies, and vendor selection. Tariff-related pricing pressures incentivize companies to reassess component sourcing, regionalize production where feasible, and pursue supplier diversification to mitigate exposure. These strategic shifts can increase near-term complexity but also accelerate longer-term investments in local manufacturing and qualified alternative supply streams.

For manufacturers of both devices and consumables, tariffs influence decisions about where to base final assembly and how to structure supplier contracts to preserve margin while maintaining regulatory compliance. End users and procurement teams respond by expanding qualification processes to include additional suppliers and by negotiating service and warranty terms that account for longer lead times. Alongside procurement adjustments, there is a renewed emphasis on inventory management practices, including buffer stock policies and demand forecasting accuracy, to reduce risk of operational disruption during tariff-induced supply volatility.

Regulatory pathways and validation requirements can complicate rapid source substitutions, especially for critical consumables such as anticoagulants, filters, and blood bags. Consequently, organizations are balancing the trade-offs between cost containment and continuity of validated processes. In summary, the tariff environment is prompting a more deliberate, resilience-focused orientation across the value chain that emphasizes supplier redundancy, regional capacity, and rigorous change control mechanisms.

Deep segmentation analysis linking product classes, automation paradigms, clinical applications, user profiles, and distribution pathways to strategic imperatives

A nuanced segmentation view reveals where value and risk converge across product types, technologies, applications, end users, and distribution channels. Product-level differentiation separates consumables from devices, with consumables encompassing anticoagulants and additives, blood bags and sets, filters, and test kits, while devices cover apheresis machines, centrifuges, pathogen reduction systems, and storage equipment. Each product class carries distinct regulatory pathways, consumable lifecycle demands, and user training requirements that influence adoption cadence and service models.

Technology segmentation distinguishes automated processing from manual processing, highlighting the growing relevance of fully automated systems and semi-automated systems in high-throughput and resource-constrained settings respectively. This technological bifurcation drives varied spending patterns and integration needs across clinical environments, with automated solutions emphasizing software integration, data management, and vendor-supported maintenance, while manual processes depend more heavily on consumable standardization and user competency.

Application-based differences, spanning blood collection, component separation, diagnostic testing, pathogen reduction, and storage and transportation, create divergent performance metrics and validation checkpoints. End users such as blood banks, diagnostic laboratories, hospitals and clinics, and research institutes impose different priorities: supply continuity and regulatory compliance dominate in blood banks, diagnostic precision and throughput guide laboratory choices, clinical compatibility and bedside ergonomics matter in hospitals, and flexibility and experimental control are paramount in research settings. Distribution channels range from direct sales for complex instrumentation to distributors and e-commerce for consumables, shaping lead times, service models, and price transparency. These segmentation insights underscore the importance of aligning product development, commercial strategy, and post-sale support with the specific needs of each user cohort and technology class.

Comparative regional assessment of regulatory complexity, infrastructure variability, and distribution imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics vary meaningfully across the Americas, Europe Middle East and Africa, and Asia Pacific, each presenting distinct regulatory, reimbursement, and infrastructure landscapes that influence adoption pathways and supplier strategies. In the Americas, procurement and clinical networks often emphasize scale and consolidation, which favors integrated solutions and service bundles that reduce operational complexity in high-volume centers. Regulatory frameworks in this region support established validation processes, and logistic networks generally facilitate centralized distribution for both devices and consumables.

Europe Middle East and Africa comprises a heterogeneous set of health systems where market access is influenced by stringent regulatory standards in some jurisdictions and constrained infrastructure in others. This diversity creates opportunities for adaptable product designs that can be configured for both resource-rich and resource-limited settings. Stakeholders operating in this region frequently must navigate cross-border regulatory harmonization, varied reimbursement rules, and the need for strong after-sales service to maintain clinical continuity.

Asia Pacific includes mature markets with advanced laboratory capabilities alongside rapidly developing healthcare systems that are scaling blood services. Local manufacturing investments and trade policies influence supply chain decisions, and end users often seek cost-effective solutions that do not compromise safety. Across the region, partnerships with regional distributors and strategic local service networks are essential to ensure uptime and regulatory compliance. Collectively, these regional insights inform how vendors should tailor market entry strategies, support models, and product configurations to align with local clinical and operational realities.

Competitive dynamics and strategic positioning that emphasize clinical validation, integrated service networks, and targeted partnerships to strengthen portfolio breadth

Competitive dynamics center on a mix of established medical device manufacturers, specialist consumable producers, and emerging technology entrants that offer novel automation or diagnostic capabilities. Leading players differentiate through a combination of validated clinical performance, comprehensive service ecosystems, and the ability to provide interoperable solutions that fit into diverse laboratory information systems and hospital workflows. Strategic partnerships and targeted acquisitions have been common tactics for firms seeking to broaden portfolios across both devices and consumables while closing capability gaps in pathogen reduction, automation, and cold chain solutions.

Mature companies typically leverage global service networks and extended warranties to support adoption in large-scale blood centers and hospital systems, whereas innovative challengers compete on modularity, lower upfront cost, and software-enabled workflow efficiencies. Distribution approaches also create competitive separation: organizations that maintain direct sales teams for complex instrument placements often embed long-term service agreements, while those that capitalize on distributor relationships or e-commerce channels emphasize scalability and rapid replenishment for consumables.

Market participants are increasingly investing in evidence generation, including clinical validations and real-world performance studies, to support procurement decisions and reimbursement discussions. This investment in clinical credibility, combined with demonstrable cost of ownership advantages and strong customer support, is central to winning both institutional contracts and long-term loyalty across clinical, laboratory, and research end users.

Actionable operational and commercial imperatives for leaders to balance innovation, supply chain resilience, and customer-centric lifecycle support

Industry leaders should prioritize a coordinated approach that balances innovation with supply chain resilience and user-centered design. Manufacturers must invest in modular automation platforms that can be configured across different throughput profiles, while ensuring compatibility with a broad range of consumables to reduce switching friction for customers. Parallel investments in robust post-sale service, remote diagnostics, and software updates will protect uptime and maintain long-term customer relationships.

Supply chain strategies should focus on qualified multi-sourcing, regional assembly capabilities, and inventory policies that reduce exposure to trade disruptions. Operational teams ought to formalize change control pathways that accelerate qualification of alternate suppliers without compromising validation requirements. Commercial teams should adapt contracting approaches to reflect total lifecycle costs rather than unit pricing alone, aligning incentives for service performance, consumable availability, and clinical outcomes.

Finally, leaders should engage proactively with regulators, standards bodies, and clinical stakeholders to shape pragmatic validation frameworks for new technologies, particularly pathogen reduction and highly automated systems. Investing in pragmatic evidence generation, clinician training programs, and interoperable data standards will accelerate adoption and de-risk procurement decisions for hospitals, blood banks, and laboratories.

Methodological framework blending primary stakeholder insights, regulatory mapping, and supplier profiling to produce pragmatic, verifiable market intelligence

This research synthesizes primary and secondary intelligence to develop an evidence-based view of the blood processing devices and consumables landscape. Primary inputs include structured interviews with clinicians, laboratory directors, procurement specialists, and technology leaders, complemented by device and consumable lifecycle documentation, clinical validation reports, and regulatory filings. Secondary inputs include peer-reviewed clinical literature, technical standards, and policy publications that contextualize product performance claims and adoption drivers.

The analytical approach combines qualitative thematic coding of stakeholder interviews with comparative product and supplier profiling to identify differentiators in design, usability, and service models. Regulatory pathways and validation requirements were mapped to product classes to clarify adoption barriers. Supply chain analysis considered component sourcing, manufacturing footprints, and distribution models, while risk assessments evaluated tariff impacts, lead time variability, and single-source dependencies. Throughout the methodology, emphasis was placed on triangulating multiple data sources to ensure robustness and to surface practical implications for procurement, R&D, and commercial strategy.

Synthesis of strategic imperatives emphasizing validated performance, adaptable service models, and resilient sourcing to secure long-term clinical and commercial success

The overarching conclusion is that successful entrants and incumbents will be those who combine validated clinical performance with adaptable, service-oriented business models and resilient supply chains. Technological advances in automation and pathogen reduction offer meaningful clinical and operational benefits, but their adoption depends on demonstrable interoperability, streamlined validation pathways, and strong post-sale support. Consumable quality and compatibility remain foundational to maintaining safety and workflow efficiency, making close collaboration between device manufacturers and consumable suppliers essential.

Regional and regulatory differences require tailored go-to-market approaches, with an emphasis on local service capabilities and evidence generation to support procurement decisions. Tariff environments and trade policy shifts add pressure to diversify sourcing and invest in regional manufacturing or assembly where feasible. Ultimately, the market rewards providers who deliver predictable outcomes, reduce complexity for clinical teams, and provide transparent total lifecycle value. Stakeholders that prioritize these imperatives will be better positioned to meet evolving clinical demands while navigating economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Devices & Consumables Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Anticoagulants And Additives
    • 8.1.2. Blood Bags And Sets
    • 8.1.3. Filters
    • 8.1.4. Test Kits
  • 8.2. Devices
    • 8.2.1. Apheresis Machines
    • 8.2.2. Centrifuges
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Storage Equipment

9. Blood Processing Devices & Consumables Market, by Technology

  • 9.1. Automated Processing
    • 9.1.1. Fully Automated Systems
    • 9.1.2. Semi Automated Systems
  • 9.2. Manual Processing

10. Blood Processing Devices & Consumables Market, by Application

  • 10.1. Blood Collection
  • 10.2. Component Separation
  • 10.3. Diagnostic Testing
  • 10.4. Pathogen Reduction
  • 10.5. Storage And Transportation

11. Blood Processing Devices & Consumables Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals And Clinics
  • 11.4. Research Institutes

12. Blood Processing Devices & Consumables Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Blood Processing Devices & Consumables Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Processing Devices & Consumables Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Processing Devices & Consumables Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Processing Devices & Consumables Market

17. China Blood Processing Devices & Consumables Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Baxter International
  • 18.7. Becton, Dickinson and Company
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. bioMerieux SA
  • 18.10. Danaher Corporation
  • 18.11. F. Hoffmann-La Roche Ltd.
  • 18.12. Fresenius Kabi
  • 18.13. Grifols, S.A.
  • 18.14. Haemonetics Corporation
  • 18.15. Immucor, Inc.
  • 18.16. Macopharma SA
  • 18.17. Terumo Corporation
  • 18.18. Thermo Fisher Scientific Inc.
  • 18.19. ThermoGenesis Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 210. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)